Skip to main navigation Skip to search Skip to main content

Correction to: Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review (Ophthalmology and Therapy, (2018), 7, 2, (293-305), 10.1007/s40123-018-0145-7)

Research output: Contribution to journalComment/debatepeer-review

Abstract

This article was originally published with the copyright: the author(s) 2018, CC-BY-NC. However, the license should be the author(s) 2018, CC-BY.

Original languageEnglish
Pages (from-to)205
Number of pages1
JournalOphthalmology and Therapy
Volume9
Issue number1
DOIs
Publication statusPublished - 1 Mar 2020

Bibliographical note

Publisher Copyright:
© 2020, The Author(s).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint

Dive into the research topics of 'Correction to: Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review (Ophthalmology and Therapy, (2018), 7, 2, (293-305), 10.1007/s40123-018-0145-7)'. Together they form a unique fingerprint.

Cite this